Related Experiment Videos
[Recent changes in informed consent for cancer treatment]
Naohito Shimoyama1, Toshifumi Murakami, Hidenori Takahashi
1Dept of Anesthesiology and Palliative Medicine, National Cancer Center Hospital, Tokyo, Japan.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|March 9, 2005
Summary
Informed consent (IC) in cancer care evolves from simple truth telling to ensuring patient understanding and autonomy in treatment decisions. Effective doctor-patient communication is crucial for delivering bad news and achieving true informed consent.
Area of Science:
- Oncology
- Medical Ethics
- Patient Communication
Context:
- The practice of informing cancer patients about their diagnosis has evolved significantly.
- Traditional 'truth telling' is shifting towards comprehensive 'informed consent' (IC).
Purpose:
- To explore the evolution of patient communication in oncology.
- To highlight the importance of informed consent in cancer care.
- To emphasize patient autonomy and the doctor-patient relationship.
Summary:
- Informed consent (IC) emphasizes patient understanding of their disease and treatment options, moving beyond basic 'truth telling'.
- Achieving true IC requires doctors to provide clear explanations, respecting patient self-determination and fostering a collaborative relationship.
- Disclosure of prognosis, while challenging, is essential for genuine IC and shared decision-making.
Impact:
- Enhances patient autonomy and engagement in cancer treatment decisions.
- Promotes stronger, trust-based relationships between oncologists and patients.
- Underscores the critical need for advanced communication skills among healthcare providers delivering difficult news.